We have previously shown that P7 rat pups injected with the N-methyl-D-aspartate receptor (NMDAR) blockerMK801 displayed robust apoptotic injury within hours after injection. Further studies from our lab suggest that loss of calcium cannot be compensated for when vulnerable neurons lack calcium buffering capabilities. Thus, to elevate calcium in these neurons prior to MK801 exposure, we injected P7 rats with the calcium channel agonist BayK 8644. Whereas BayK 8644 did not induce apoptosis by itself, it was found to block MK801-induced injury in a dose-dependent manner. Reversal of MK801 toxicity was complete in the caudate-putamen, partial in the somatosensory cortex but was not observed in the retrosplenial cortex. These results suggest that postnatal brain injury resulting from agents that block the NMDAR, which include commonly used anesthetics as well as drugs of abuse, may be prevented in vulnerable neurons by compensatory increases in calcium prior to exposure to these antagonists.
KeywordsRat; Postnatal; Apoptosis; Set point hypothesis; MK801; Dizocilpine We and others have previously shown that blockade of the Nmethyl-D-aspartate receptor (NMDAR) in postnatal day 7 (P7) rat pups causes profound apoptotic injury [2,12]. In contrast, at P21, agents that block this receptor no longer promote cell death. Numerous mechanisms have been proposed for this age-dependent injury such as loss of neuronal calcium [10][11][12], disruption of synaptic circuitry, up-regulation of NMDAR protein or absence of trophic support [1,8,9,13,14].We proposed some time ago that at P7 the regulatory mechanisms that determine optimal calcium levels may not have matured in some neuronal populations [12]. In its simplest form, this calcium set point (CSP) hypothesis [3] states that excessive gain or loss of calcium will result in neuronal injury. In the case of NMDAR blockade, an inability to adapt to loss of calcium entry pushes vulnerable neurons towards cell death [3,[10][11][12]. Indeed, we were the first to show that MK801-induced expression of the pro-apoptotic marker activated caspase-3 (AC3) in P7 rat brains was almost exclusively found in cells that lacked the calcium binding proteins calbindin (CB), calretinin (CR), or parvalbumin (PV) [5], and that gain of these proteins (in particular PV) coincided with loss of MK801 sensitivity [6,7].